Alkermes (ALKS) Interest & Investment Income (2010 - 2026)
Alkermes (ALKS) reported Interest & Investment Income of $5.34 million for Q2 2026, down 51.8% from $11.09 million a year earlier and down 37.4% from the prior quarter.
Alkermes (ALKS) Interest & Investment Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Alkermes' Interest & Investment Income came in at $37.96 million, down 12.8% year-over-year; for FY2025, it came in at $45.3 million, up 6.7% from FY2024.
- Interest & Investment Income has increased for four consecutive years, with a five-year compound annual growth rate of 45.4% (FY2020 to FY2025).
- By year, Interest & Investment Income came in at $42.45 million in FY2024 (+37.6%), $30.85 million in FY2023 (+304.4%), $7.63 million in FY2022 (+216.8%) and $2.41 million in FY2021 (-65.4%).
- The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income since Q1 2023.
- Year over year, Interest & Investment Income gained in six of the last eight quarters, with an average decline of 0.9%.
- The high point for year-over-year Interest & Investment Income in five years was Q1 2023 (growth of 766.7%); the low point was Q3 2021 (a decline of 66.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8.54 million (Q1 2026), $12.13 million (Q4 2025) and $11.94 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Alkermes | 6.99 Bn | 4.13 Bn | 397.90 Mn | 5.34 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.34 Mn |
| Mar 31, 2026 | 8.54 Mn |
| Dec 31, 2025 | 12.13 Mn |
| Sep 30, 2025 | 11.94 Mn |
| Jun 30, 2025 | 11.09 Mn |
| Mar 31, 2025 | 10.14 Mn |
| Dec 31, 2024 | 11.40 Mn |
| Sep 30, 2024 | 10.92 Mn |
| Jun 30, 2024 | 10.74 Mn |
| Mar 31, 2024 | 9.40 Mn |
| Dec 31, 2023 | 9.75 Mn |
| Sep 30, 2023 | 9.37 Mn |
| Jun 30, 2023 | 6.77 Mn |
| Mar 31, 2023 | 4.97 Mn |
| Dec 31, 2022 | 3.92 Mn |
| Sep 30, 2022 | 2.24 Mn |
| Jun 30, 2022 | 896,000.00 |
| Mar 31, 2022 | 573,000.00 |
| Dec 31, 2021 | 453,000.00 |
| Sep 30, 2021 | 468,000.00 |
Alkermes Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ALKS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();